Clinical Trial Update: Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Cediranib in adults with locally advanced or metastatic hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Cediranib (Cediranib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 2 | Status: COMPLETED